This record was last updated February 28, 2024 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the safety and efficacy of urinary kallidinogenase treatment in patients with large artery atherosclerotic acute ischemic stroke.
Protocol Amendment History
1 amendment
This ClinicalTrials.gov record has been amended once since 2023-11-14.